...
search icon
inmb-img

INmune Bio Inc Share Price

INMB
NAQ
$1.345
-$0.01
(-0.74%)
1D
Industry: Biotechnology Sector: Health Care

INmune Bio Inc Analyst Forecast

INmune Bio Inc Share Price Chart

INmune Bio Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$35.89M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
676.43K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.74
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.33 L
$9.56 H
$1.345

About INmune Bio Inc, Common Stock

INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida. more

Industry: BiotechnologySector: Health Care

INmune Bio Inc Stock Returns

Time FrameINMBSectorS&P500
1-Week Return-14.01%0.91%-0.82%
1-Month Return-15.63%1.46%1.28%
3-Month Return-10%3.33%3.98%
6-Month Return-46.64%16.03%6.73%
1-Year Return-85.29%9.1%12.24%
3-Year Return-85.56%21.02%72.07%
5-Year Return-92.82%36.15%75.69%
10-Year Return-83.1%138.89%258.38%

INmune Bio Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue10.92K181.00K374.00K155.00K14.00K[{"date":"2020-12-31","value":2.92,"profit":true},{"date":"2021-12-31","value":48.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.44,"profit":true},{"date":"2024-12-31","value":3.74,"profit":true}]
Cost of Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit10.92K181.00K374.00K155.00K14.00K[{"date":"2020-12-31","value":2.92,"profit":true},{"date":"2021-12-31","value":48.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.44,"profit":true},{"date":"2024-12-31","value":3.74,"profit":true}]
Gross Margin100.00%100.00%100.00%100.00%100.00%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses12.24M29.33M26.32M29.90M42.65M[{"date":"2020-12-31","value":28.7,"profit":true},{"date":"2021-12-31","value":68.78,"profit":true},{"date":"2022-12-31","value":61.72,"profit":true},{"date":"2023-12-31","value":70.1,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(12.23M)(29.15M)(25.95M)(29.74M)(42.63M)[{"date":"2020-12-31","value":-1222767600,"profit":false},{"date":"2021-12-31","value":-2915300000,"profit":false},{"date":"2022-12-31","value":-2595100000,"profit":false},{"date":"2023-12-31","value":-2974100000,"profit":false},{"date":"2024-12-31","value":-4263500000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(12.10M)(30.34M)(27.30M)(30.01M)(42.08M)[{"date":"2020-12-31","value":-1209915900,"profit":false},{"date":"2021-12-31","value":-3034000000,"profit":false},{"date":"2022-12-31","value":-2729900000,"profit":false},{"date":"2023-12-31","value":-3000800000,"profit":false},{"date":"2024-12-31","value":-4208200000,"profit":false}]
Income Taxes(128.52K)1.19M1.35M(29.74M)-[{"date":"2020-12-31","value":-9.53,"profit":false},{"date":"2021-12-31","value":88.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2206.31,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(12.10M)(30.34M)(25.95M)(27.43M)(42.08M)[{"date":"2020-12-31","value":-1209915900,"profit":false},{"date":"2021-12-31","value":-3034000000,"profit":false},{"date":"2022-12-31","value":-2595100000,"profit":false},{"date":"2023-12-31","value":-2743300000,"profit":false},{"date":"2024-12-31","value":-4208200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(12.10M)(30.34M)(28.65M)(30.01M)(42.08M)[{"date":"2020-12-31","value":-1209915900,"profit":false},{"date":"2021-12-31","value":-3034000000,"profit":false},{"date":"2022-12-31","value":-2864700000,"profit":false},{"date":"2023-12-31","value":-3000800000,"profit":false},{"date":"2024-12-31","value":-4208200000,"profit":false}]
EPS (Diluted)(1.01)(1.86)(1.52)(1.67)(2.11)[{"date":"2020-12-31","value":-101,"profit":false},{"date":"2021-12-31","value":-186,"profit":false},{"date":"2022-12-31","value":-152,"profit":false},{"date":"2023-12-31","value":-167,"profit":false},{"date":"2024-12-31","value":-211,"profit":false}]

INmune Bio Inc Ratios

INmune Bio Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

INMB
Cash Ratio 3.77
Current Ratio 4.17

INmune Bio Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

INMB
ROA (LTM) -50.59%
ROE (LTM) -155.77%

INmune Bio Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

INMB
Debt Ratio Lower is generally better. Negative is bad. 0.24
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.76

INmune Bio Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

INMB
Trailing PE NM
Forward PE NM
P/S (TTM) 744.39
P/B 1.52
Price/FCF NM
EV/R 237.36
EV/Ebitda NM

FAQs

What is INmune Bio Inc share price today?

INmune Bio Inc (INMB) share price today is $1.345

Can Indians buy INmune Bio Inc shares?

Yes, Indians can buy shares of INmune Bio Inc (INMB) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INMB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of INmune Bio Inc be purchased?

Yes, you can purchase fractional shares of INmune Bio Inc (INMB) via the Vested app. You can start investing in INmune Bio Inc (INMB) with a minimum investment of $1.

How to invest in INmune Bio Inc shares from India?

You can invest in shares of INmune Bio Inc (INMB) via Vested in three simple steps:

  • Click on Sign Up or Invest in INMB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in INmune Bio Inc shares
What is INmune Bio Inc 52-week high and low stock price?

The 52-week high price of INmune Bio Inc (INMB) is $9.56. The 52-week low price of INmune Bio Inc (INMB) is $1.33.

What is INmune Bio Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of INmune Bio Inc (INMB) is

What is INmune Bio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of INmune Bio Inc (INMB) is 1.52

What is INmune Bio Inc dividend yield?

The dividend yield of INmune Bio Inc (INMB) is 0.00%

What is the Market Cap of INmune Bio Inc?

The market capitalization of INmune Bio Inc (INMB) is $35.89M

What is INmune Bio Inc's stock symbol?

The stock symbol (or ticker) of INmune Bio Inc is INMB

How Can Investors Use INmune Bio Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of INmune Bio Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether INmune Bio Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from INmune Bio Inc shares for Indian investors?

When investing in INmune Bio Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the INmune Bio Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare INmune Bio Inc share price with other stocks in the same sector?

Rather than merely checking the share price of INmune Bio Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that INmune Bio Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top